Which one is better for refractory/relapsed acute B-cell lymphoblastic leukemia: Single-target (CD19) or dual-target (tandem or sequential CD19/CD22) CAR T-cell therapy?
暂无分享，去创建一个
Y. Wang | A. Sun | Depei Wu | Xiaowen Tang | H. Qiu | Yue Han | M. Miao | Suning Chen | C. Fu | Jia Yin | H. Dai | Q. Cui | Lei Yu | S. Xue | Zheng Li | Zhengming Jin | Chunxiu Yang | Caixia Li | W. Cui | Sining Liu | Xinyue Zhang | Xiao Yang | Z. Jin